Article Details

UWC-19 by UWELL Biopharma for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval

Retrieved on: 2023-09-14 16:16:06

Tags for this article:

Click the tags to see associated articles and topics

UWC-19 by UWELL Biopharma for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval. View article details on hiswai:

Excerpt

UWC-19 is under clinical development by UWELL Biopharma and currently in Phase II for Primary Mediastinal B-Cell Lymphoma.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up